AtriCure
ATRC
AtriCure (ATRC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.18
- EPS estimate
- −$0.00
- EPS surprise
- +10688.24%
- Revenue surprise
- +1.19%
- Revenue
- $153.6M
- Revenue estimate
- $151.8M
- Reported
- Jul 23, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 23, 2026 | −$0.00 | $0.18 | +10688.24% | $153.6M | SEC |
| Q1 2026 | May 5, 2026 | −$0.06 | $0.00 | +100.00% | $141.2M | SEC |
| Q4 2025 | Feb 17, 2026 | −$0.09 | $0.04 | +146.08% | $140.5M | SEC |
| Q3 2025 | Oct 29, 2025 | −$0.11 | −$0.01 | +91.06% | $134.3M | SEC |
| Q2 2025 | Jul 29, 2025 | −$0.17 | −$0.13 | +22.20% | $136.1M | SEC |
| Q1 2025 | Apr 29, 2025 | −$0.23 | −$0.14 | +37.78% | $123.6M | SEC |
| Q4 2024 | Feb 12, 2025 | −$0.20 | −$0.33 | −63.12% | $124.3M | SEC |
| Q3 2024 | Oct 29, 2024 | −$0.19 | −$0.17 | +12.78% | $115.9M | SEC |
| Q2 2024 | Jul 30, 2024 | −$0.17 | −$0.17 | −1.13% | $116.3M | SEC |
| Q1 2024 | May 1, 2024 | −$0.23 | −$0.28 | −22.06% | $108.9M | SEC |
| Q4 2023 | Feb 15, 2024 | −$0.22 | −$0.21 | +6.58% | $106.5M | SEC |
| Q3 2023 | Nov 1, 2023 | −$0.30 | −$0.20 | +34.32% | $98.3M | SEC |
| Q2 2023 | Jul 25, 2023 | −$0.30 | −$0.11 | +62.86% | $100.9M | SEC |
| Q1 2023 | May 2, 2023 | −$0.31 | −$0.14 | +54.85% | $93.5M | SEC |
| Q4 2022 | Feb 21, 2023 | −$0.18 | −$0.09 | +48.89% | $88.0M | SEC |
| Q3 2022 | Nov 1, 2022 | −$0.26 | −$0.27 | −5.14% | $83.2M | SEC |
| Q2 2022 | Aug 2, 2022 | −$0.29 | −$0.32 | −9.18% | $84.5M | SEC |
| Q1 2022 | May 3, 2022 | −$0.32 | −$0.33 | −3.13% | $74.6M | SEC |
| Q4 2021 | Feb 15, 2022 | −$0.29 | −$0.30 | −3.45% | $73.2M | SEC |
| Q3 2021 | Nov 3, 2021 | −$0.33 | $2.11 | +748.03% | $70.5M | SEC |
Quarterly revenue
Frequently asked questions
When did AtriCure (ATRC) last report earnings?
AtriCure last reported on Jul 23, 2026, covering fiscal Q2 2026.
Did ATRC beat earnings estimates?
Yes. AtriCure reported EPS of $0.18 for Q2 2026 against a −$0.00 estimate — a 10688.24% beat.
How much revenue did ATRC report last quarter?
AtriCure reported $153.6M in revenue for Q2 2026, against a consensus estimate of $151.8M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.